Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Acalabrutinib> ?p ?o }
Showing triples 1 to 45 of
45
with 100 triples per page.
- Acalabrutinib abstract "Acalabrutinib, (rINN, ACP-196) is a 2nd generation BTK inhibitor developed by Acerta Pharma.It is designed to be more selective (fewer side-effects) than ibrutinib.As of 2015 it is in late stage clinical trials for relapsed chronic lymphocytic leukemia. Interim results are encouraging : 95% overall response rate.It is also in another 20 clinical trials (alone and in combination) for various cancers.".
- Acalabrutinib casNumber "1420477-60-6".
- Acalabrutinib iupacName "4-{8-Amino-3-[(2S)-1-(2-butynoyl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl}-N-(2-pyridinyl)benzamide".
- Acalabrutinib thumbnail Acalabrutinib.svg?width=300.
- Acalabrutinib wikiPageID "48820352".
- Acalabrutinib wikiPageLength "3470".
- Acalabrutinib wikiPageOutDegree "7".
- Acalabrutinib wikiPageRevisionID "703909432".
- Acalabrutinib wikiPageWikiLink Acerta_Pharma.
- Acalabrutinib wikiPageWikiLink B-cell_chronic_lymphocytic_leukemia.
- Acalabrutinib wikiPageWikiLink Brutons_tyrosine_kinase.
- Acalabrutinib wikiPageWikiLink Category:Cancer_treatments.
- Acalabrutinib wikiPageWikiLink Category:Human_proteins.
- Acalabrutinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Acalabrutinib wikiPageWikiLink Ibrutinib.
- Acalabrutinib wikiPageWikiLinkText "Acalabrutinib".
- Acalabrutinib wikiPageWikiLinkText "acalabrutinib".
- Acalabrutinib casNumber "1420477".
- Acalabrutinib chemicalFormula "C26H23N7O2".
- Acalabrutinib chemspiderid "36764951".
- Acalabrutinib inchi "1".
- Acalabrutinib inchikey "WDENQIQQYWYTPO-IBGZPJMEBM".
- Acalabrutinib iupacName "4".
- Acalabrutinib molecularWeight "465.507".
- Acalabrutinib smiles "CC#CCN1CCC[C@H]1c2ncc4cccCNc5ccccn5".
- Acalabrutinib stdinchi "1".
- Acalabrutinib stdinchikey "WDENQIQQYWYTPO-IBGZPJMESA-N".
- Acalabrutinib wikiPageUsesTemplate Template:As_of.
- Acalabrutinib wikiPageUsesTemplate Template:Drugbox.
- Acalabrutinib wikiPageUsesTemplate Template:Pharma-stub.
- Acalabrutinib wikiPageUsesTemplate Template:Reflist.
- Acalabrutinib subject Category:Cancer_treatments.
- Acalabrutinib subject Category:Human_proteins.
- Acalabrutinib subject Category:Tyrosine_kinase_inhibitors.
- Acalabrutinib hypernym Inhibitor.
- Acalabrutinib type ChemicalSubstance.
- Acalabrutinib type Drug.
- Acalabrutinib type ChemicalObject.
- Acalabrutinib type Thing.
- Acalabrutinib type Q8386.
- Acalabrutinib comment "Acalabrutinib, (rINN, ACP-196) is a 2nd generation BTK inhibitor developed by Acerta Pharma.It is designed to be more selective (fewer side-effects) than ibrutinib.As of 2015 it is in late stage clinical trials for relapsed chronic lymphocytic leukemia. Interim results are encouraging : 95% overall response rate.It is also in another 20 clinical trials (alone and in combination) for various cancers.".
- Acalabrutinib label "Acalabrutinib".
- Acalabrutinib wasDerivedFrom Acalabrutinib?oldid=703909432.
- Acalabrutinib depiction Acalabrutinib.svg.
- Acalabrutinib isPrimaryTopicOf Acalabrutinib.